“Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if ‘expensive’ voriconazole is only used on demand?” (2006) Swiss Medical Weekly, 136(3940), pp. 624–624. doi:10.4414/smw.2006.11259.